BrightEdge operates at the intersection of investment and innovation to define and catalyze scientific, social, and sustainable impact across the continuum of cancer care. As the innovation and impact investment arm of the American Cancer Society (ACS's), we leverage our legacy in cancer research and patient support to identify and thoughtfully invest in actionable and scalable solutions that address the most critical areas of unmet need and generate financial returns to bolster and sustain ACS’s lifesaving work for decades to come.
We are not a typical investor. Given our distinct vantage and position, we are poised to lead and shape the future of cancer innovation and impact investing.
We know the challenges and can define unmet need to a degree others cannot.
We identify promising solutions to yield positive returns while making a positive impact.
We’re equipped to navigate, connect, and facilitate across a complex health care landscape.
Together, we can accelerate innovation to address cancer from every angle.
BrightEdge is led by a world-class team of experienced investors, operators, and entrepreneurs who are all personally dedicated to realizing ACS’s vision to end cancer as we know it, for everyone.
Our team is purpose-built to execute BrightEdge’s integrated operating model across innovation, investment, and impact, with world-leading internal and external advisors to support mission alignment and bolster scientific and medical expertise.
BrightEdge channels the historical and operational expertise of the American Cancer Society to identify the most impactful scientific discoveries, promising entrepreneurs, and emerging companies poised to change the landscape of cancer care.
We provide financial investment and strategic support directly to these entrepreneurs and companies to drive three-dimensional impact and sustain ACS’s lifesaving work by:
BrightEdge Annual Report 2024
October 7, 2025Pegasus Park Hosts American Cancer Society’s BrightEdge Golden Ticket Pitch Competition - Focus Daily News
October 24, 2024BrightEdge Roundtable and White Paper
May 21, 2024
Become a part of BrightEdge and help strengthen our ability to make a transformative impact by making a tax-deductible donation. With your help, we invest directly into the companies and entrepreneurs that are changing the landscape of cancer care, while simultaneously creating a long-term, sustainable revenue stream for ACS initiatives that will improve the lives of millions of people facing cancer and their families.
Reach out to learn more about becoming an impact donor, how other venture funds can invest alongside BrightEdge, or how BrightEdge selects oncology startups for its portfolio.
Connect with us
